A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Neuro-Oncology | October 30, 2017 | Volume: 20 | Issue: 5 | Pages: 666-673
10.1093/neuonc/nox209
| PMID 29126203